Recent insider sale at Enanta Pharmaceuticals reflects possi...
Recent insider sale at Enanta Pharmaceuticals reflects possible contentment with lower company valuation. The absence of insider buying over past year raises caution for potential investors.
Independent Director Of Enanta Pharmaceuticals Sold 73% Of Their Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment